FTC Chief Andrew Ferguson on the Trump Vision for Antitrust
Odd Lots17 Mars 2025

FTC Chief Andrew Ferguson on the Trump Vision for Antitrust

When Donald Trump won in November, one of the things that Wall Street was excited about was an expected liberalization of merger rules. There was a popular view that under Chair Lina Khan, the Biden FTC was overly stringent about what deals it would let go through, and that the new administration would give the greenlight more often. But at least so far, reality hasn't proven to be so simple. There hasn't been a big merger wave yet. And, in fact, the FTC under new Chair Andrew Ferguson has decided to keep the merger guidelines that Khan put in place. So does this mean continuity? At a live episode of the podcast taped in Washington DC, we spoke with Ferguson about the Trump administration's vision for antitrust. He talked about his philosophy of keeping corporate power in check and the tests he's using to preserve a competitive environment. He also walked us through the long history of the FTC and the notion of consumer welfare, plus why he thinks a more expansive interpretation of the term (beyond just lower prices) is in keeping with the history of conservative legal thought.

Read More: New DOJ Antitrust Chief Builds Team From Prior Administrations
Trump’s FTC Moves Ahead With Broad Microsoft Antitrust Probe

Only Bloomberg.com subscribers can get the Odd Lots newsletter in their inbox — now delivered every weekday — plus unlimited access to the site and app. Subscribe at bloomberg.com/subscriptions/oddlots

See omnystudio.com/listener for privacy information.

Avsnitt(1190)

Episode 5: 6,000 Years of Interest Rates

Episode 5: 6,000 Years of Interest Rates

(Bloomberg) -- What better way to prepare for what may be the first U.S. rate hike in almost a decade than to tour 6,000 years of interest-rate history? This week, Joe and Tracy speak with NYU Stern f...

7 Dec 201522min

Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?

Episode 4: Can a Hedge Funder Cut Prescription Drug Costs?

(Bloomberg) -- Hedge-fund manager Kyle Bass has a plan that could cut the high cost of prescription drugs in the U.S. -- and make himself a lot of money. The strategy: Take short positions in a number...

30 Nov 201519min

Episode 3: The Strange Story Behind the Beanie Babies Bubble

Episode 3: The Strange Story Behind the Beanie Babies Bubble

(Bloomberg) -- Two market bubbles stand out from the late 1990s. Technology stocks that were supposed to make everyone a zillionaire. The other: A series of mass-produced stuffed animals priced at $5 ...

23 Nov 201522min

Episode 2: Under the Hood of the $8 Trln Corporate Bond Market

Episode 2: Under the Hood of the $8 Trln Corporate Bond Market

(Bloomberg) -- It's definitely big and it might be broken. It's the bond market! The corporate bond market, that is. In the second episode of Odd Lots, hosts Tracy Alloway and Joe Weisenthal talk corp...

16 Nov 201520min

Episode 1: Tom Keene on Mathiness and His Favorite Guitar

Episode 1: Tom Keene on Mathiness and His Favorite Guitar

(Bloomberg) -- Tracy Alloway and Joe Weisenthal kick off the Odd Lots podcast by interviewing the legendary television and radio host Tom Keene. On Tom’s mind this week: Fat tail risks, mathiness on W...

6 Nov 201522min

The Odd Lots Preview

The Odd Lots Preview

(Bloomberg) -- Welcome to Episode Zero of the Odd Lots podcast! Every week, hosts Joe Weisenthal and Tracy Alloway take you on a not-so random weekly walk through hot topics in markets, finance and ec...

4 Nov 20153min

Populärt inom Business & ekonomi

framgangspodden
rss-jossan-nina
badfluence
varvet
svd-tech-brief
rss-borsens-finest
rss-svart-marknad
uppgang-och-fall
avanzapodden
bathina-en-podcast
fill-or-kill
lastbilspodden
rss-inga-dumma-fragor-om-pengar
rss-dagen-med-di
tabberaset
borsmorgon
rss-kort-lang-analyspodden-fran-di
rikatillsammans-om-privatekonomi-rikedom-i-livet
24fragor
montrosepodden